Applied Biology, Inc., Irvine, California.
Dermatol Ther. 2018 Sep;31(5):e12686. doi: 10.1111/dth.12686. Epub 2018 Aug 28.
The National Institutes of Health (US NIH, 2018) estimates that in the US approximately 50 million men and 30 million women suffer from AGA (also known as pattern hair loss). Minoxidil is the only topical drug for the treatment of both female and male pattern hair loss. In the US, minoxidil is approved over-the-counter (OTC) at a maximum concentration of 5%. In this review, we summarize the findings of the pivotal studies used in support of the drug's approval as well as recent discoveries and novel developments in the use of minoxidil for the treatment of AGA.
美国国立卫生研究院（NIH）估计，在美国约有 5000 万男性和 3000 万女性患有 AGA（也称为模式性脱发）。米诺地尔是治疗女性和男性AGA 的唯一外用药物。在美国，米诺地尔的最大浓度为 5%，可在柜台上购买。在这篇综述中，我们总结了支持该药物批准的关键性研究结果，以及米诺地尔治疗 AGA 的最新发现和新进展。
